Literature DB >> 28780

Soluble NADH-cytochrome b5 reductase from rabbit liver cytosol: partial purification and characterization.

D Lostanlen, A Vieira de Barros, A Leroux, J C Kaplan.   

Abstract

A soluble form of NADH-cytochrome b5 reductase (NADH: ferricytochrome b5 oxidoreductase, EC 1.6.2.2) was found in the cytosolic fraction of rabbit liver. The partially purified enzyme was strictly specific for NADH. It catalyzed the reduction of several substrates such as the methemoglobin-ferrocyanide complex (Hegesh, E. and Avron, M. (1967) Biochim. Biophys. Acta 146, 91-101) (apparent Km: 8 micrometer), potassium ferricyanide (apparent Km: 10 micrometer) and ferricytochrome b5 (apparent Km: 15 micrometer). Upon acrylamide gel isoelectro-focusing followed by specific staining, the enzyme was resolved into four bands (isoelectric pH: 7.05, 6.70, 6.50 and 6.30). The optimum pH of activity with ferricytochrome b5 as a substrate was 6.5. The estimated molecular weight was 25 000--30 000. The enzyme was unsensitive to cyanide. It was strongly inhibited by p-hydroxymercuribenzoate. The cytosolic liver cytochrome b5 reductase was immunologically related to the soluble cytochrome b5 reductase from human and rabbit red-cells, and to the microsomal cytochrome b5 reductase from rabbit liver.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 28780     DOI: 10.1016/0005-2744(78)90288-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Cytochrome b₅ reductase-cytochrome b₅ as an active P450 redox enzyme system in Phanerochaete chrysosporium: atypical properties and in vivo evidence of electron transfer capability to CYP63A2.

Authors:  Khajamohiddin Syed; Chandramohan Kattamuri; Thomas B Thompson; Jagjit S Yadav
Journal:  Arch Biochem Biophys       Date:  2011-03-02       Impact factor: 4.013

2.  Transcriptional and translational mechanisms of cytochrome b5 reductase isoenzyme generation in humans.

Authors:  A Leroux; L Mota Vieira; A Kahn
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

3.  Membrane-bound cytochrome b5 reductase (methemoglobin reductase) in human erythrocytes. Study in normal and methemoglobinemic subjects.

Authors:  D Choury; A Leroux; J C Kaplan
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

4.  Evidence for a free N-acetylneuraminic acid-hydroxylating enzyme in pig mandibular gland soluble fraction.

Authors:  C J Mukuria; W D Mwangi; A Noguchi; G P Waiyaki; T Asano; M Naiki
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

5.  NADH cytochrome b5 reductase activity in lymphoid cell lines. Expression of the defect in epstein Barr virus transformed lymphoblastoid cell lines from patients with recessive congenital methemoglobinemia.

Authors:  D Lostanlen; G Lenoir; J C Kaplan
Journal:  J Clin Invest       Date:  1981-07       Impact factor: 14.808

6.  Development and validation of a spectrophotometric assay for measuring the activity of NADH: cytochrome b5 reductase in human tumour cells.

Authors:  H M Barham; R Inglis; E C Chinje; I J Stratford
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.